Relay Therapeutics, Inc.
RLAY
$12.47
-$0.31-2.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -272.71M | -276.48M | -297.59M | -311.55M | -333.39M |
| Total Depreciation and Amortization | 2.85M | 3.56M | 4.29M | 4.91M | 5.28M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 52.80M | 60.77M | 63.88M | 68.41M | 64.55M |
| Change in Net Operating Assets | 3.70M | -23.31M | -19.04M | -23.19M | -8.44M |
| Cash from Operations | -213.36M | -235.46M | -248.46M | -261.42M | -271.99M |
| Capital Expenditure | -26.00K | -410.00K | -409.00K | -637.00K | -622.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 183.26M | 193.21M | 186.74M | 21.08M | -8.53M |
| Cash from Investing | 183.24M | 192.80M | 186.33M | 20.45M | -9.15M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 140.39M | 1.60M | 1.47M | 220.34M | 221.23M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 140.39M | 1.60M | 1.47M | 220.34M | 221.23M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.26M | -41.05M | -60.65M | -20.63M | -59.91M |